Page URL:

Blood test could warn of return of skin cancer

11 December 2017
Appeared in BioNews 930

UK scientists say they are closer to developing an 'early warning system' for the return of cancer in patients using a simple blood test.

A study in 161 patients with malignant melanoma found a blood test for specific gene mutations was predictive of which patients would relapse after surgery to remove their cancers.

'Being able to develop an early warning system that will predict if a cancer will return could make a real difference to patients,' said Professor Karen Vousden, Cancer Research UK's (CRUK's) chief scientist. 'If follow up research shows that this test can be used to inform treatment decisions and improve outlook, it could be a game-changer in our ability to deal with advanced skin cancer.'

The team led by scientists at the CRUK Manchester Institute and the Christie NHS Foundation looked for circulating tumour DNA (ctDNA) – shed by cancer cells – into the blood for two known mutations associated with skin cancer. They analysed blood samples taken after surgery for mutations in the genes BRAF and NRAS – linked to 70 percent of melanomas.

Patients who had ctDNA in their blood after surgery had a shorter time to relapse than those without any detectable levels of ctDNA, found the study. And patients with detectable ctDNA for either mutation were much less likely to be alive five years later, with 33 percent surviving, than those whose blood showed no tumour DNA of whom 65 percent were still alive.

'For some patients with advanced melanoma, their cancer will eventually return. We have no accurate tests to predict who these patients will be, so our findings are really encouraging,' said Professor Richard Marais, lead researcher and director of the CRUK institute, based at the University of Manchester. 'If we can use this tumour DNA test to accurately predict if cancer is going to come back, then it could help doctors decide which patients could benefit from new immunotherapies.'

The study was published in Annals of Oncology.

Blood test could predict skin cancer's return
Cancer Research UK |  6 December 2017
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
Annals of Oncology |  3 November 2017
Simple blood test could reveal return of skin cancer
The Independent |  6 December 2017
Simple blood test could reveal risk of skin cancer coming back
Manchester Evening News |  6 December 2017
9 August 2021 - by Georgina Al-Badri 
The mechanism underlying DNA damage that leads to melanoma has been found to be a specific mutation caused by UVB radiation in sunlight...
5 March 2018 - by Anna Mallach 
Bacteria commonly found on skin could be used as a treatment against skin cancer, researchers at the University of California, San Diego, have found...
18 December 2017 - by Dr Loredana Guglielmi 
Scientists in the USA have found a novel non-coding gene that alters proliferation in cancer cells to help tumour development...
26 June 2017 - by Charlotte Spicer 
A new three-in-one blood test could progress personalised treatment for patients with prostate cancer...
12 June 2017 - by Dr Hannah Somers 
A highly-sensitive DNA blood test could help detect cancer years before tumours are detected...
2 May 2017 - by Dr Loredana Guglielmi 
Blood tests for tumour DNA could predict relapse of the most common type of lung cancer up to one year before clinical signs show up on patient's scans...
13 March 2017 - by Dr Loredana Guglielmi 
Researchers have developed a new blood test that can not only detect cancer at an early stage, but can also indicate where the tumour is located in the body...
14 March 2016 - by Dr Lucy Freem 
Scientists have developed a blood test that captures tumour DNA from stray cancer cells circulating in the blood and allows them to monitor genetic changes in skin cancer...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.